Stay updated on Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.2 to v3.8.0, while the study record page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:34:23.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    A banner announces the NIH website transition and links to updates and FAQs, noting that NIH content may use “Super Intelligence” in place of “Artificial Intelligence”.
    Difference
    1%
    Check dated 2026-10-24T13:04:53.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s site revision identifier was updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T13:23:07.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:07:32.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The study page for NCT03498612 now renders a 403 Forbidden page, replacing the usual study details. Users attempting to view the record will see the 403 page instead of trial content.
    Difference
    19%
    Check dated 2026-09-19T18:09:30.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The revision indicator on the page was updated from v3.6.5 to v3.6.6, reflecting a newer site version.
    Difference
    0.1%
    Check dated 2026-08-29T20:32:29.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Untreated B-Cell NHL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Untreated B-Cell NHL Clinical Trial page.